Ulmer W T, Zimmerman I
Arzneimittelforschung. 1980;30(4):686-8.
The effect of a single dose of 100 mg metoprolol tartrate (Lopresor) on airway flow resistance, intrathoracic gas volume, systolic and diastolic blood pressure and heart rate was studied in 10 patients with obstructive disease of the airways in a double-blind trial versus placebo. Metoprolol showed no significant effect on the flow resistance in the airways, although in some patients a clear increase in flow resistance was evident. The effect on pulse rate was significant, while that on blood pressure was less pronounced. Therefore the effect of metoprolol on airway flow resistance is similar to that of atenolol and pindolol, while it can be assumed to be superior to propranolol in this respect. The beta 2-stimulator fenoterol is capable of lowering the flow resistance in patients with chronic obstructive disease of the airways extremely satisfactorily, and equally well after metoprolol or after placebo.
在一项双盲试验中,对10例气道阻塞性疾病患者研究了单剂量100毫克酒石酸美托洛尔(倍他乐克)对气道阻力、胸腔内气体容量、收缩压和舒张压以及心率的影响,并与安慰剂进行了对比。美托洛尔对气道阻力无显著影响,尽管在一些患者中气道阻力明显增加。对脉搏率有显著影响,而对血压的影响则不那么明显。因此,美托洛尔对气道阻力的影响与阿替洛尔和吲哚洛尔相似,而在这方面可以认为它优于普萘洛尔。β2激动剂非诺特罗能够极其令人满意地降低慢性气道阻塞性疾病患者的气道阻力,在服用美托洛尔后或服用安慰剂后效果同样良好。